PathAI Launches AIM-HER2 Breast Cancer, an Artificial Intelligence-Powered HER2 Scoring Algorithm for Biopharma Research and Clinical Labs
Pathology market’s first algorithm to use additive multiple instance learning (aMIL) heatmaps to provide greater transparency for how AI predictions are made
Source: itnonline.com